EAN News

Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy

In this study recently published in the New England Journal of Medicine, the authors conducted a phase 1, dose-escalation, open-label trial including 45 healthy adults, 18 to 55 years of age, who received two vaccinations, 28 days apart, with candidate vaccine mRNA-1273 (which encodes the stabilised prefusion SARS-CoV-2 spike protein) in a dose of 25 μg, 100 μg, or 250 μg.

In this controlled, open-label trial recently published in the New England Journal of Medicine, the authors randomly assigned patients who were hospitalised with COVID-19 to receive either oral or intravenous dexamethasone (at a dose of 6 mg once daily) for up to 10 days or usual care.

The main objective of World Brain Day is to increase public awareness and promote advocacy related to brain health.

The COVID-19 Pandemic and Neurology Published by the Turkish Neurological Society COVID-19 COMMITTEE

Acute symptomatic seizures and SARS-CoV-2 encephalitis in COVID-19

The urgent need for coordination of research efforts and strong EU leadership in health research embedded in a European Council for Health Research have been identified as key policy topics during the BioMed Alliance Spring meeting.

This EAN clinical practice guideline aims to provide practical help to clinicians caring for people with severe, progressive multiple sclerosis (MS).

In May 2020, the EAN published for the first time guidelines for the management of medication overuse headache (MOH).

The EAN virtual congress was a real success and we are happy to announce a re-opening of the webcasts from July 11-14, 2020.

We congratulate the winners of the EAN Tournament during the EAN Virtual Congress.

COVID Breaking news: CNS injury biomarkers elevated in COVID patients

Estonia is a small country in Northeastern Europe, the northernmost of the three Baltic states.

In order to fill educational gap, CoCoCare developed a state-of-the-art educational program for residents across Europe

The study is funded by the European Commission and the first results will be used as input for a meeting of Ministries of Health in the EU in July 2020 under the current German EU Presidency, and addressing the future governance for primary and secondary use of health data, also in light of the current COVID-19 pandemic.